Skip to main content
DeutschDE
European Commission logo print header

Development of oral fixed-dose Artesumate-based combinations for the treatment of uncomplicated malaria

Ziel

This proposal aims at the fast-track pharmaceutical development and clinical validation of two artesunate-based fixed-dose combinations for the treatment of malaria, including the preparation of relevant registration files. The goal is to make these new combination drugs available for use as quality, safe, viable, adapted and affordable drugs in the endemic countries. This project constitutes a missing link in promoting antimalarial policy changes towards combination therapy, and the successful implementation thereof. It builds upon the expertises of R& D centres in the EU and different regions in the South, which are being mobilised in an international effort to dramatically improve the available malaria treatment tools.

Wissenschaftliches Gebiet

Programm/Programme

Thema/Themen

Aufforderung zur Vorschlagseinreichung

Data not available

Finanzierungsplan

CSC - Cost-sharing contracts

Koordinator

DRUGS FOR NEGLECTED DISEASES INITIATIVE
EU-Beitrag
Keine Daten
Adresse
Rue du Docteur Roux 25-28
75015 PARIS
Frankreich

Auf der Karte ansehen
Gesamtkosten
Keine Daten

Beteiligte (9)

Diese Seite teilen

Herunterladen

Letzte Aktualisierung: 13 Juni 2006

Mein Booklet

Permalink: https://cordis.europa.eu/project/id/ICA4-CT-2002-10046/de

European Union, 2024